NewsRx

Search our medical news database

AngioDynamics Inc.

AngioDynamics to Launch VenaCure EVLT, New Brand for Varicose Vein Treatment

Published in Surgery Litigation and Law Weekly, November 28th, 2008

AngioDynamics Inc. (NASDAQ:ANGO) announced it will launch a new varicose vein therapy brand, VenaCure EVLT, at the American College of Phlebology (ACP) 22nd Annual Congress, November 6th to 9th at the Marco Island Marriott Resort & Spa in Florida. The new brand will encompass the best of AngioDynamics' VenaCure(R) product line as well as EVLT(R), a product line which AngioDynamics recently rescued from the bankruptcy of Diomed Inc.

Participants at the ACP Congress will find the AngioDynamics booth directly across from the entrance to the exhibit hall in booths 101 through 107.

"As the name conveys, our new brand will be everything you liked about...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook